Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Oct 26, 2018 at 11:30 AM EDT

Gilead Stumbles Despite Solid Earnings Beat

Gilead shares retreated on Friday after it reported mixed third-quarter financial results late on Thursday.

Chris Lange | Oct 25, 2018 at 9:00 AM EDT

Major Pharma Short Sellers Hike Their Bets

The October 15 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | Oct 25, 2018 at 8:25 AM EDT

Merck Earnings Reflect Huge Increase in Keytruda Sales, Outlook Raised for FY18

Pharmaceutical maker Merck beat adjusted earnings estimates but missed slightly on revenues when it reported Q3 results Thursday morning. Investors…

Chris Lange | Oct 25, 2018 at 8:20 AM EDT

Short Sellers Hike Their Bets in Major Biotechs

The October 15 short interest data have been compared with the previous report, and short interest in most of the…

Lee Jackson | Oct 25, 2018 at 7:10 AM EDT

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

These four top pharmaceutical companies have longstanding franchises with huge sales and revenues, and their dividend-paying stocks look like outstanding choices…

Douglas A. McIntyre | Oct 24, 2018 at 10:55 AM EDT

Huge Study Shows American Kids Don’t Get Enough Exercise

A large new study released today shows that American children fall short of the amount of exercise they need each…

Chris Lange | Oct 24, 2018 at 9:40 AM EDT

Are Investors Giving Alexion Enough Credit for Earnings?

Alexion Pharmaceuticals reported better-than-expected quarterly results before the markets opened on Wednesday.

Chris Lange | Oct 23, 2018 at 1:50 PM EDT

Orchard RX Announces Potential Pricing for IPO

Biopharmaceutical company Orchard RX is offering more than 13 million shares in an initial public offering valued up to more…

Chris Lange | Oct 23, 2018 at 1:15 PM EDT

Pfizer and Bain Capital Partner Up to Tackle CNS Disorders

Pfizer, in collaboration with Bain Capital, announced the creation of Cerevel Therapeutics, a new biopharmaceutical company focused on developing drug…

Chris Lange | Oct 23, 2018 at 11:40 AM EDT

How Proteostasis Will Capitalize on Its Big Cystic Fibrosis Win

Proteostasis Therapeutics shares pulled back on Tuesday after the company announced that it would be conducting a secondary offering.

Chris Lange | Oct 22, 2018 at 10:55 AM EDT

Why Mirati Therapeutics Is Sinking

Mirati shares dropped on Monday after the company announced updated positive clinical data from its midstage study in non-small cell…

Jon C. Ogg | Oct 22, 2018 at 10:51 AM EDT

Entasis Therapeutics Called to Have Huge Upside from Analysts, But Poor IPO Performance Clouds Sentiment

Analysts very bullish on Entasis Therapeutics ETTX

Chris Lange | Oct 22, 2018 at 10:05 AM EDT

Axonics Announces Potential Pricing for IPO

Medical technology company Axonics Modulation Technologies is offering more than 6 million shares in an initial public offering valued up…

Chris Lange | Oct 21, 2018 at 10:15 AM EDT

Top Biotech Earnings Reports to Watch This Week

Here is a preview of some of the world’s largest players in the health care sector reporting earnings this coming…

Lee Jackson | Oct 20, 2018 at 9:20 AM EDT

Jefferies Out With 5 Biotech Stocks Under $10 With Gigantic Upside Potential

Here are five biotech stocks that are rated Buy by the Jefferies analysts, are trading under the $10 level and…

1 … 115 116 117 118 119 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Gilead Stumbles Despite Solid Earnings Beat

Major Pharma Short Sellers Hike Their Bets

Merck Earnings Reflect Huge Increase in Keytruda Sales, Outlook Raised for FY18

Short Sellers Hike Their Bets in Major Biotechs

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

Huge Study Shows American Kids Don’t Get Enough Exercise

Are Investors Giving Alexion Enough Credit for Earnings?

Orchard RX Announces Potential Pricing for IPO

Pfizer and Bain Capital Partner Up to Tackle CNS Disorders

How Proteostasis Will Capitalize on Its Big Cystic Fibrosis Win

Why Mirati Therapeutics Is Sinking

Entasis Therapeutics Called to Have Huge Upside from Analysts, But Poor IPO Performance Clouds Sentiment

Axonics Announces Potential Pricing for IPO

Top Biotech Earnings Reports to Watch This Week

Jefferies Out With 5 Biotech Stocks Under $10 With Gigantic Upside Potential

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

50% of Nvidia Employees Are Now Worth Over $25 Million: How Nvidia Created Thousands of Millionaires

Want $2,200 in Passive Income? Invest $50,000 Into These 3 Dividend Stocks

Does Lumentum’s 1,444% Surge Come to an End Tomorrow?

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Ben Carlson Calls Out the Goldman Survey That Says 40% of $500K Earners Live Paycheck-to-Paycheck. The Definition Is the Problem.

50% of Nvidia Employees Are Now Worth Over $25 Million: How Nvidia Created Thousands of Millionaires

Want $2,200 in Passive Income? Invest $50,000 Into These 3 Dividend Stocks

Health and Healthcare Articles

All Health and Healthcare Articles

Gilead Stumbles Despite Solid Earnings Beat

Major Pharma Short Sellers Hike Their Bets

Merck Earnings Reflect Huge Increase in Keytruda Sales, Outlook Raised for FY18

Short Sellers Hike Their Bets in Major Biotechs

Why Large Cap Pharmaceuticals Will Hold Up in a Bear Market

Huge Study Shows American Kids Don’t Get Enough Exercise

Are Investors Giving Alexion Enough Credit for Earnings?

Orchard RX Announces Potential Pricing for IPO

Pfizer and Bain Capital Partner Up to Tackle CNS Disorders

How Proteostasis Will Capitalize on Its Big Cystic Fibrosis Win

Why Mirati Therapeutics Is Sinking

Entasis Therapeutics Called to Have Huge Upside from Analysts, But Poor IPO Performance Clouds Sentiment

Axonics Announces Potential Pricing for IPO

Top Biotech Earnings Reports to Watch This Week

Jefferies Out With 5 Biotech Stocks Under $10 With Gigantic Upside Potential

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

50% of Nvidia Employees Are Now Worth Over $25 Million: How Nvidia Created Thousands of Millionaires

Want $2,200 in Passive Income? Invest $50,000 Into These 3 Dividend Stocks

Does Lumentum’s 1,444% Surge Come to an End Tomorrow?

Featured Reads

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Ben Carlson Calls Out the Goldman Survey That Says 40% of $500K Earners Live Paycheck-to-Paycheck. The Definition Is the Problem.